Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
115 results about "Fasting blood sugar" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Assistant hypoglycemic healthcare biscuits
InactiveCN101642152AEliminate generationTo promote metabolismDough treatmentBakery productsDiseaseCholesterol
The invention discloses an assistant hypoglycemic healthcare biscuit belonging to a healthcare food. The assistant hypoglycemic healthcare biscuit contains the following components which are measuredby grams and shown in a table. The food containing dietary fiber is prepared for diabetes patients to eat, not only complements daily dietary fiber, but also favorably regulates the circadian rhythm,prevents the blood sugar from rising, has the assistant healthcare function for decreasing the cholesterol of the postprandial blood sugar and the fasting blood sugar of the diabetes patients, prevents diseases, promotes rehabilitation and integrates functions, convenience, recreation, and the like into a whole.
Owner:河南梦想食品有限公司
Atraumatic quick-action blood-sugar measuring apparatus and application method thereof
ActiveCN100998507AImprove accuracyLow costSensorsBlood characterising devicesCommunication interfacePower switching
A non-invasive fast blood sugar tester able to monitor multiple patient at same time is composed of a casing, a panel with at least one horn opening from which a central axle of a heating head is projected, a display screen, a power supply port, a computer communication port, a power switch and several indicating lamps, a central control chip, a microwave generator connected to said heating head, a DC power supply, a microwave power regulator, temp detecting and controlling unit, temp regulator, time regulator, and temp sensor on the top of said central axle of heating head. Its test method is also disclosed.
Owner:江苏精策医疗科技有限公司
Non-wound rapid blood sugar detecting method and its detecting instrument
InactiveCN1775174ARelieve painAvoid the risk of infectionSensorsBlood characterising devicesHuman bodyMonitoring temperature
The present invention relates to a non-traumatic fast blood sugar detection method and its detection apparatus. It is characterized by that it adopts an external heating source to heat the tested skin and deep layer tissue of human body, and utilizes a temperature monitor to dynamically monitor temperature, then the temperature change characteristic value obtained by monitoring temperature of skin and deep layer tissue of tested human body can be inputted into the non-traumatic fast blood sugar detection apparatus central chip, said central chip can be used for making comparison and analysis of said temperature change characteristic value with previously built-in related curve or correspondent relationship formula blood sugar correspondent value and making treatment so as to obtain the blood sugar value of tested human body and said blood sugar value can be displayed on the display screen of said detection apparatus.
Owner:何宗彦
Preparation method and application of total flavone and total polysaccharide in cyclocarya paliurus leaves
PendingCN110051726AHigh purityLow priceMetabolism disorderNatural extract food ingredientsGlucose uptakeFood material
The invention provides a preparation method and application of total flavone and total polysaccharide in cyclocarya paliurus leaves. The method comprises the steps of taking cyclocarya paliurus leavesas raw materials, executing extraction by an ethanol-water solvent, executing extraction by an organic solvent, executing elution by a chromatographic column and by macroporous resin to obtain totalflavone, conducting extraction on cyclocarya paliurus leaf dregs by hot water, executing precipitation, removing protein, and adsorbing impurities by macroporous resin to obtain total polysaccharide.Studies show that the total triterpenes, the total flavones, the total polysaccharides and their composition prepared by the method can effectively increase glucose uptake of 3T3-L1 adipocytes, obviously reduce the fasting blood glucose level of the hereditary diabetes db / db mice, has antidiabetic activity, and can be used for preparing products such as antidiabetic medicines, health foods, functional foods and the like for reducing blood sugar. The invention develops the comprehensive preparation method of total flavones and total polysaccharides in cyclocarya paliurus leaves and applicationof the mehtod in resisting diabetes, and provides a basis and a new application direction for popularization, utilization and deep processing of traditional Chinese medicinal materials and new food raw materials.
Owner:ZHEJIANG UNIV
Moringa leaf extract with blood sugar lowering activity and preparation method thereof
ActiveCN108785342AGood hypoglycemic effectLower fasting blood sugarMetabolism disorderFood ingredient functionsOral glucoseUltrafiltration
The invention discloses a moringa leaf extract with blood sugar lowering activity and a preparation method thereof. The preparation method comprises the following steps: crushing and sieving, performing alkali treatment, performing protease enzymolysis, performing cellulase enzymolysis, performing high-pressure homogenization, performing high-temperature extraction, performing low-temperature high-speed centrifugation, performing ultrafiltration separation and concentration, performing protease enzymolysis, performing low-temperature high-speed centrifugation, performing secondary ultrafiltration separation and concentration, performing freeze drying and the like to obtain the moringa leaf extract with the blood sugar lowering activity. The extract has the polysaccharide content of 30% orabove; an animal experimental model of a type-2 diabetic rat verifies that the extract has good blood sugar lowering activity and can effectively reduce the fasting blood glucose of the type-2 diabetic rat and enhance the oral glucose tolerance dosage thereof; the acting effect of the extract is similar to that of metformin with the same dosage. An extracting technology is simple, the whole technological process can meet a food-grade requirement, and the moringa leaf extract can be applied to the field of medicines, health-care products, food and the like.
Owner:SOUTH CHINA UNIV OF TECH
Application of irisin in preparation of antihyperglycemic medicines
ActiveCN104623640ALower blood sugarConvenient treatmentPeptide/protein ingredientsMetabolism disorderLow insulinPancreatic hormone
The invention discloses a method for providing a new intervention target for preparation of antihyperglycemic medicines and using the irisin into development of diabetes-related medicines to prepare relatively good medicines for treating diabetes. After STZ / HFD-induced mice with diabetes are subjected to subcutaneous injection with irisin, the fasting serum glucose level is significantly reduced; the insulin sensitivity is significantly improved; by irisin, gluconeogenesis is reduced and glycogen synthesis is increased; the application proves that irisin is capable of significantly improving glucose metabolic disorder and insulin resistance in diabetes, is an effective target for treating diabetes, and can be developed as a novel antihyperglycemic medicine or medicine target; and a new way and means are provided for detection and treatment of diabetes.
Owner:NANJING MEDICAL UNIV
Lactobacillus reuteri capable of intervening in metabolic syndrome and application
InactiveCN112322527AImproves resistance to oxidative stressHelp maintain structureMilk preparationBacteriaBiotechnologyPancreatic hormone
The invention discloses lactobacillus reuteri capable of intervening in metabolic syndrome and application, and belongs to the technical field of microorganisms. The lactobacillus reuteri CCFM1145 screened by the invention can significantly improve the increase of serum total cholesterol content of metabolic syndrome mice caused by high fat diet. The weight rise of metabolic syndrome individuals is relieved, and the daily diet intake and the energy efficiency are remarkably reduced. Fasting blood glucose and insulin resistance index levels of metabolic syndrome individuals are significantly improved. The rise of Romboutsia in the intestinal tract caused by high fat diet is obviously relieved. The levels of anti-oxidative stress CAT and SOD in the liver are remarkably improved, serum lipopolysaccharide endotoxin is inhibited, and a colon barrier structure is maintained. The lactobacillus reuteri CCFM1145 disclosed by the invention can be used for preparing pharmaceutical compositions and fermented foods for relieving diseases such as metabolic syndrome, non-alcoholic fatty liver disease and diabetes mellitus and the like, and has a very wide application prospect.
Owner:JIANGNAN UNIV
Application of bifidobacterium adolescentis CCFM1061 in preparation of functional microbial agents, foods and/or medicines
ActiveCN110354148AImprove fasting blood sugarImprove Total Cholesterol ElevationMetabolism disorderUnknown materialsBifidobacterium adolescentisPerfluorooctanoic acid
The invention discloses application of bifidobacterium adolescentis CCFM1061 in preparation of functional microbial agents, foods and / or medicines. The bifidobacterium adolescentis CCFM1061 can be rapidly colonized in the intestinal tracts, can remarkably improve fasting blood glucose and oral glucose tolerance of type 2 diabetes induced by STZ and high-fat diet and decrease the area under a curvewhen glucose tolerance is reduced, can remarkably alleviate the increase of total cholesterol and the decrease of high-density lipoprotein cholesterol in serum of the type 2 diabetes caused by STZ and high-fat diet, can remarkably alleviate the insulin resistance of the type 2 diabetes, can remarkably improve the level of inflammation in liver tissues of the type 2 diabetes, and can remarkably alleviate the pathological damage of the pancreas, liver and other tissues of the type 2 diabetes. In addition, the bifidobacterium adolescentis CCFM1061 has strong adsorption capacity on perfluorooctanoic acid (PFOA), and has the capacity of relieving PFOA toxicity.
Owner:JIANGNAN UNIV
Application of leonurine to preparation of medicament for treating 2-type diabetes
The invention belongs to the field of traditional Chinese medicine manufacturing, and relates to application of leonurine to preparation of a medicament for treating 2-type diabetes. Animal experiments prove that the fasting blood glucose of a 2-type diabetes mouse, i.e., a db / db mouse, can be lowered by the leonurine, and the tolerance of oral glucose is improved; and meanwhile, fasting plasma insulin is increased, the plasma triglyceride is reduced and the content of the plasma high-density lipoprotein is increased. Experiment results also show that the expression of liver glucose metabolic enzymes such as glucokinase, glucose-6-phosphatase and phosphoenolpyruvate carboxyl enzyme is adjusted by the leonurine in an Akt dependent mode; and the biological response of an inflammatory mediator, such as generation of TNF (Tumor Necrosis Factor)-alpha, degradation of IkB-alpha and subsequent phosphorylation of NF-kBp65, is suppressed. Through the leonurine, the inflammatory state of the 2-type diabetes can be corrected, and the symptoms of the 2-type diabetes can be improved; and the leonurine can be used as a treatment medicament to be applied to the treatment of the 2-type diabetes.
Owner:FUDAN UNIV
Benzothiazole derivative, preparation method and application thereof
ActiveCN103044414APromote growthLower systolic blood pressureOrganic chemistryMetabolism disorderChemistryDiabetes model
The invention relates to a benzothiazole derivative, a preparation method and an application thereof, wherein the benzothiazole derivative is 2-m-aniline benzothiazole-1H-pyrazole-3-formamide, and the structural formula of the benzothiazole derivative is shown in the description. The benzothiazole derivative disclosed by the invention can accelerate the growth of saccharomycetes, strengthen the metabolic activity of the saccharomycetes, obviously reduce the plasma triglyceride, the total cholesterol and the high-density lipoprotein of C57 BL / 6J mice fed with high-fat feedstuff, reduce the systolic pressure and the diastolic pressure of model mice, reduce the fasting blood glucose of the model mice, improve the sugar tolerance of the mice, affect the expression of SIRT1 and relevant genes (FOXO1, P53, PPAB gamma and PGC-1 alpha), and obviously improve the sugar and fat metabolism of diabetic model mice. Therefore, the benzothiazole derivative can be applied to preparing medicines for preventing and treating diabetes mellitus and complications of the diabetes mellitus.
Owner:斯芬克司药物研发(天津)股份有限公司
Preparation of fresh ginseng juice and application of fresh ginseng juice in heath care and medical treatment
InactiveCN103505487AExcellent indicatorsReduce statistical differenceMetabolism disorderPlant ingredientsPhysiologyInsulin humulin
The invention relates to a beverage, and particularly relates to a beverage containing a fresh ginseng juice. The beverage is prepared by squeezing fresh ginseng with addition of water and is sterilized by an ultrahigh pressure device. In vivo animal experiments show that the fresh ginseng juice can significantly reduce fasting blood glucose of 2-type diabetes, increase the fasting insulin level and improve the islet function.
Owner:郑毅男
Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome X
InactiveUS20070196515A1Improve and eliminate cardiovascular riskImprove or eliminate at least one cardiovascular risk factorOrganic active ingredientsBiocideHealth benefitsBinge eating
The present invention provides for compositions and related methods using extracts from the Cissus quadrangularis plant to improve and eliminate various cardiovascular risk factors and metabolic risk factors that cause Syndrome X. Controlled university studies demonstrated that 300 mg Cissus quadrangularis plant extract provided to obese humans daily for six weeks was effective to provide numerous health benefits including weight loss, improving the bodies fat burning mechanisms, increasing serum serotonin levels which causes appetite suppression and prevents binge eating and / or emotional eating, reducing total cholesterol, LDL cholesterol, triglyceride levels, fasting blood sugar levels and blood pressure, and increasing HDL or “good” cholesterol levels. Additional university controlled experiments also showed that extracts from the Cissus quadrangularis plant were effective in increasing lipase inhibition, α-amylase inhibition, α-glucosidase inhibition in rodents and that large doses of Cissus quadrangularis plant extracts were not toxic to rodents.
Owner:KOTHARI SHIL
Exenatide oral nanoparticle
The invention provides an exenatide oral nanoparticle and a preparation method thereof. The exenatide oral nanoparticle contains exenatide and CSK-chitosan. The exenatide oral nanoparticle can substantially improve the oral administration absorption effect, improves the bioavailability, and realizes fast blood sugar lowering effect and stable blood sugar.
Owner:SHANDONG LUYE PHARMA CO LTD
Health products adapted for diabetic and production method thereof
The invention discloses a kinds of health product adapted for diabetic patients which mainly comprises astragalus root, gen-seng, dried rehmannia root, oligosaccharide, oriental water plantain rhizome, tea polysaccharides by a finite weight proportion. The health product has the auxiliary function for lowering blood sugar.
Owner:SHANDONG LONGLIVE BIO TECH CO LTD
Bacterial strain as well as composition and application
ActiveCN113069475AReduce weightLower fasting blood sugarPowder deliveryBacterial antigen ingredientsHepatic inflammationBacterial strain
The invention discloses a bacterial strain as well as a composition and application, and relates to the technical field of strain separation and application. The Cristinia sp. provided by the invention can be applied to treatment or prevention of liver function impairment and liver function impairment related diseases, alimentary canal mucosal injury and alimentary canal mucosal injury related diseases, diabetes, obesity and obesity related diseases. The inventor verifies that the Cristinia sp. provided by the invention has no toxic or side effect on the kidney and can reduce the weight of the liver; the initial steatohepatitis focus can be treated; fat accumulation of liver cells can be slowed down; AST and ALT in serum can be reduced; and abdominal white fat inflammatory lesion can be reduced. The Cristinia sp. can also repair the digestive tract mucosa, recover the barrier function of the mucosa, and prevent and treat intestinal leakage, peptic ulcer and other diseases caused by barrier function impairment. The Cristinia sp. also has the effects of reducing fasting blood-glucose of a body, regulating insulin level and reducing body fat of mammals, and has the effects of preventing and treating diabetes and improving the metabolic function of obese patients.
Owner:MOON (GUANGZHOU) BIOTECH CO LTD
Chinese-western composite medicine for treating diabetes and its preparing method
InactiveCN1554422ARelief of clinical symptomsSymptoms did not improve significantlyMetabolism disorderUnknown materialsWestern medicineSide effect
The composition Chinese-Western medicine for treating diabetes consists of 28 kinds of Chinese medicinal materials including tuckahoe, prepared rhizome of rehmannia, figwort root, trichosanthes root, astragalus root, etc. and Western medicine Glibenclamide. It has the toxic side effect of the Western medicine overcome and fast blood sugar reducing rate as well as simple preparation process, determined curative effect, lasting medicine effect and no bad reaction.
Owner:董瑞明
Wolfberry and sea-buckthorn fruit juice and preparation method thereof
InactiveCN107252024AEasy to integrateStrong fragranceFood ingredient as colourFood ingredient as taste affecting agentSaccharumSucrose
Owner:格尔木云朵枸杞科技有限责任公司
Making method of konjac noodle products suitable for diabetics
InactiveCN108294259AAppearance greenBright appearanceNatural extract food ingredientsFood ingredient as mouthfeel improving agentGlucomannanFast blood sugar
The invention provides a making method of konjac noodle products suitable for diabetics. The making method comprises the following steps of refining glucomannan powder, performing charging, performingrefining, performing discharging to obtain noodles, performing shaping and performing cooking. The made noodle products are strong basicity foods, green and bright in appearance, and smooth and tenacious in mouth feel, and the pH value is 11.5-12. After the konjac noodle products suitable for diabetics are eaten by patients with fasting blood sugar being less than or equal to 9.5 mmol\l for 6 months, the blood sugar can be reduced to 6.1mmol\l or below; after the konjac noodle products suitable for diabetics are eaten by patients with fasting blood sugar being greater than 9.5 and smaller than 10 mmol\l for 9 months, the blood sugar can be reduced to 6.1mmol\l or below; after the konjac noodle products suitable for diabetics are eaten by patients with fasting blood sugar being greater than 10 and smaller than 11 mmol\l for 12 months, the blood sugar can be reduced to 6.1mmol\l or below; and after the konjac noodle products suitable for diabetics are eaten by patients with fasting blood sugar being greater than 11 and smaller than 16 mmol\l for 12 months or more, the fasting blood sugar can be reduced to 7mmol\l or below.
Owner:SHANDONG HEARUN DIETARY HALL CO LTD
Tricyclic Heterocyclic Derivatives and Methods of Use
The present invention relates to novel Tricyclic Heterocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Heterocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. R1 is formula (Ia), (Ib) or (Ic); R2 is alkvl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl or heterocycloalkyl. any of which can be optionally substituted with R11; M1 is —CH—. —C(halo)- or —N—; Y is —C(O)—, —S—. —S(O)—, —S(O)2—, —CH2— or —O—, such that Y is not —O— when an adjacent atom is N.
Owner:DE LERA RUIZ MANUEL +5
Hypoglycemic peptide and drug use thereof
ActiveCN103641889AAbsorptionPromote absorptionPeptide/protein ingredientsMetabolism disorderGlucose utilizationOxygen
The invention provides a hypoglycemic peptide, which is provided with an amino acid sequence as shown in SEQ ID NO: 1. The invention also provides a modified peptide of the hypoglycemic peptide. A chemical group, an amino acid, polypeptide, protein or PEG is connected to the N end, C end or intermediate residue of the hypoglycemic peptide. The hypoglycemic peptide provided by the invention can perfect the glucose tolerance of KK-Ay mice, reinforce the glucose utilization ability of the KK-Ay mice, significantly improve the fasting blood glucose and glucose tolerance of the KK-Ay mice, significantly reduce serum total cholesterol and serum triglyceride, significantly perfect the SOD level, reduce the MDA level and protect the body cells against oxygen free radicals, the hypoglycemic peptide has glucose and lipid reducing functions and can resist metabolic syndrome. The hypoglycemic peptide can be used for preparing drugs or healthcare products for treating and / or preventing diabetes or hyperlipidemia.
Owner:山东康泽健康管理咨询有限公司
Application of triacetyl-3-hydroxyphenyl adenosine in preparing medicines for improving insulin resistance and related diseases
InactiveCN105663152AIncreased sensitivityImprove the immunityOrganic active ingredientsMetabolism disorderTriacetyl-3-hydroxyphenyladenosineDisease
The invention discloses application of triacetyl-3-hydroxyphenyl adenosine, as shown in Formula (I), in preparing medicines for preventing, relieving or treating insulin resistance and related diseases, wherein the insulin resistance related diseases include type II diabetes, abnormal glucose tolerance, hyperinsulinemia, impaired glucose tolerance, hypertension, coronary disease, obesity and non-alcoholic fatty liver disease. Specifically, the triacetyl-3-hydroxyphenyl adenosine disclosed by the invention can improve the insulin sensitivity of peripheral tissues and the glucose tolerance of a body and the triacetyl-3-hydroxyphenyl adenosine can reduce insulin content, so that insulin resistance is improved (as shown in the Description).
Owner:INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI +1
Bifidobacterium adolescentis ccfm1061, its fermented food and preparation method of bacterial agent
ActiveCN110331118BReduce absorptionImprove liver damageMilk preparationBacteriaBiotechnologyLiver steatosis
Owner:JIANGNAN UNIV
Chinese medicinal composition for assisting in decreasing blood sugar and preparation method thereof
ActiveCN103736052AThe formula is scientific and reasonableGood adjustment functionMetabolism disorderPlant ingredientsSide effectFasting blood sugar
The invention discloses a Chinese medicinal composition for assisting in decreasing blood sugar and a preparation method thereof. The composition is prepared from medicinal materials of panaxadiol saponins, astragalus, large-head atractylodes rhizome, epimedium herb, malaytea scurfpea fruit, south dodder seed, dried ginger, oriental waterplantain rhizome, Indian buead, dogwood and the like as raw materials. The invention further provides a preparation method of the Chinese medicinal composition for assisting in decreasing blood sugar. By using the composition provided by the invention, the fasting blood sugar of a rat with high blood sugar due to mesoxyalyurea can be lowered effectively, and the sugar tolerance can be well regulated. Compared with a control sample group, the Chinese medicinal composition is remarkably lower in fasting blood sugar and remarkably superior in sugar tolerance regulating effect. Experiment results show that the Chinese medicinal composition has a better blood sugar degreasing effect than the conventional traditional Chinese medicine, and is high in safety and free from side effects.
Owner:GUANGXI WUZHOU PHARMA GRP
Assistant hypoglycemic momordica grosvenori preparation and preparation method thereof
InactiveCN105596401AGood enzyme inhibitory activityPromote absorptionMetabolism disorderPill deliveryIGT - Impaired glucose toleranceMedicine
The invention relates to an assistant hypoglycemic momordica grosvenori preparation, and particularly provides dry powder which is extracted from immature momordica grosvenori with a growing period of 30-80 days and of which the total saponin content is 60%-90%, and a preparation method of the dry powder in preparation of assistant hypoglycemic oral liquid, particle, capsule and tablet. The assistant hypoglycemic momordica grosvenori preparation is capable of reducing fasting blood-glucose of patients with impaired glucose tolerance and the patients with type 2 diabetes mellitus, and simultaneously is capable of obviously inhibiting blood glucose rise after the meal and relieving the degree of insulin resistance.
Owner:GUANGXI UNIV OF CHINESE MEDICINE
Composition for regulating blood sugar as well as preparation method and application thereof
ActiveCN113274481APromote proliferationImprove endurance levelsOrganic active ingredientsHydrolysed protein ingredientsIsomaltooligosaccharideNutrition
The invention discloses a composition for regulating blood sugar as well as a preparation method and application thereof. The composition comprises inulin, peanut peptide, galactooligosaccharide, isomaltooligosaccharide, beta-glucan and vitamin C; wherein the inulin is an inulin mixture with the polymerization degree of 24-60. The inulin is used as a main raw material, the polymerization degree of the inulin is optimized, and meanwhile, various prebiotics, dietary fibers and vitamin C are added, so that the components play a synergistic role, proliferation of intestinal probiotics can be promoted, and the intestinal environment can be improved; in addition, fermentation of beneficial bacteria can be promoted to generate short-chain fatty acid, the sensitivity of insulin of type II diabetes patients is improved, food intake is reduced, then blood sugar is effectively controlled, fasting blood glucose of the diabetes patients is remarkably reduced, and glycated serum protein and glucose tolerance levels are improved. The composition provided by the invention is comprehensive in nutrition and excellent in blood sugar reducing effect, and has important significance on treatment and prevention and treatment of diabetes.
Owner:湖北明德医疗科技有限责任公司
Traditional Chinese medicine composition for treating prediabetes
ActiveCN102836358ASolve technical problemsMetabolism disorderPlant ingredientsAngelica Sinensis RootRadix Astragali seu Hedysari
The invention relates to the technical field of a medicine for treating diabetes mellitus, in particular to the traditional Chinese medicine composition for treating prediabetes, i.e., the impaired glucose tolerance including impaired glucose tolerance and fasting blood-glucose damage stages. The traditional Chinese medicine composition is prepared by the following raw materials in parts by weight: 1 to 10 parts of rhizoma atractylodis macrocephalae, 1 to 10 parts of dried lily bulb, 2 to 10 parts of radix rehmanniae recen, 2 to 10 parts of radix astragali, 1 to 5 parts of rhizoma coptidis, 2 to 6 parts of semen coicis, 2 to 6 parts of angelica sinensis in Min county and 2 to 6 parts of flos sophorae immaturus. The traditional Chinese medicine composition provided by the invention is suitable for prediabetes, i.e., the impaired glucose tolerance including impaired glucose tolerance and fasting blood-glucose damage stages, which mainly aims at shortness of breath and tiredness and polydipsia and polydipsia which are caused by deficiency of both qi and yin and damp and hot internal resistance, sticky greasy mouth, and the like. The traditional Chinese medicine composition is capable of tonifying qi and yin, clearing heat and expelling damp, and promoting blood circulation to remove blood stasis.
Owner:张定华
Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof
ActiveCN103191170AMetabolism disorderMacromolecular non-active ingredientsCooking & bakingSide effect
The invention discloses a healthcare product for the auxiliary treatment of type 2 diabetes, and a preparation method thereof, and relates to the medical healthcare field. The preparation method of the healthcare product comprises the following steps: taking towel gourd seeds of towel gourds, cleaning, baking in a 20-50DEG C baking box, shelling, grinding the shelled towel gourd seeds to form fine powder, and adding auxiliary materials to prepare a pharmaceutically acceptable formulation. The cooperation of the healthcare product and other blood sugar reducing medicines allows the fasting blood sugar of a type 2 diabetic patient to be stably reduced, and the effect to be more substantial than the single use of the blood sugar reducing medicines and blood sugar reducing healthcare products, and has no side effects.
Owner:GENSUN INST OF BIOMEDICINE
NAD<+> composition for intervening in high fasting blood glucose in early stage of diabetes as well as preparation method and use method of NAD<+> composition
PendingCN113893262APromote reproductive growthInhibition of reproductionPowder deliveryOrganic active ingredientsVitamin CWarm water
Owner:WUHAN INULING BIOTECH
Collagen zymolyte with blood sugar reducing effect as well as preparation method and application of collagen zymolyte
ActiveCN114349849AImprove oral glucose toleranceRealize enzymatic hydrolysis and controlled releaseConnective tissue peptidesHydrolysed protein ingredientsOral glucoseCollagenan
The invention discloses a collagen zymolyte with a blood sugar reducing effect and a preparation method and application thereof, the zymolyte contains Gly-Pro-type peptide composed of 4-7 amino acid residues, and the mass ratio is 30-45%; the general formula of the sequence of the Gly-Pro-type peptide consisting of 4 to 7 amino acid residues is Gly-Pro-Xaa1-Gly-[Xaa2] r-[Xaa3] s-[Gly] t. According to the preparation method provided by the invention, the zymolyte with strong DPP-IV inhibition activity is prepared for the first time, and the DPP-IV inhibition rate of the zymolyte is as high as 68% when the final concentration is 1mg / mL; the zymolyte is rich in Gly-Pro-type peptide composed of 4-7 amino acid residues, and the peptide yield is as high as 45%; animal experiments prove that the zymolyte can regulate fasting blood-glucose of rats with type 2 diabetes mellitus and improve the oral glucose tolerance of the rats with type 2 diabetes mellitus.
Owner:SOUTH CHINA UNIV OF TECH +1
Traditional Chinese medicine composition for treating diabetic nephropathy and application thereof
InactiveCN110787263ALower serum creatinineReduce contentAnthropod material medical ingredientsMetabolism disorderEfficacyThelial cell
The invention discloses an application of a traditional Chinese medicine composition in preparation of drugs for treating diabetes and diabetic nephropathy. The traditional Chinese medicine composition is prepared from radix astragali, fructus lycii, rhizoma dioscoreae, semen coicis, radix scrophularise, radix glehniae, herba ecliptae, dried human placenta, cortex eucommiae, radix notoginseng, herba leonuri, leeches, cicada ecdysis, semen plantaginis and radix achyranthis bidentatae. According to the application, proven by experimental researches, the traditional Chinese medicine composition has a very good effect of reducing fasting blood-glucose of rats suffering from the diabetic nephropathy, and the content of blood serum creatinine, urea nitrogen, kidney index and urinary protein in the rats suffering from the diabetic nephropathy can be remarkably lowered. Meanwhile, the traditional Chinese medicine composition has a very good effect of preventing renal tubular epithelial cells from fibrosis. Novel pharmaceutical preparations for clinical indications can be developed.
Owner:雷允上药业集团有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com